Floatz logo

TRIAMCINOLONE ACETONIDE 21-ACETATE

Osteoarthritis (OA) of the Knee

Brixton Biosciences, Inc.Small moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

30 Active assets in the Osteoarthritis (OA) of the Knee cohort.

Asset / SponsorPhaseRating
Duloxetine
Orthopaedic Arthroscopy Knee and Shoulder Clinic
Phase 4BBB
Naproxen
Pfizer
Phase 3BB
TRIAMCINOLONE HEXACETONIDE
Kastamonu University
Phase 4BB
DEXAMETHASONE
Poznan University of Medical Sciences
Phase 4BB
Oxycodone
Riku Antero Palanne
Phase 3BB

View all 50 →

Same molecule, other indications

TRIAMCINOLONE ACETONIDE 21-ACETATE is also rated in:

obesity disorderDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →